PUBLISHER: The Business Research Company | PRODUCT CODE: 1946559
PUBLISHER: The Business Research Company | PRODUCT CODE: 1946559
Mobile cardiac telemetry systems are sophisticated devices used for real-time detection and recording of abnormal heart rhythms. They continuously monitor a patient's heart activity and automatically send data to a central monitoring center. This enables prompt analysis and timely intervention by healthcare professionals. MCT systems are commonly employed for diagnosing and managing arrhythmias and other cardiac conditions.
The primary types of mobile cardiac telemetry systems are multiple lead mobile cardiac telemetry systems and mobile cardiac telemetry patches. Multiple lead mobile cardiac telemetry systems utilize several electrodes attached to a patient's body to continuously monitor heart activity. These systems are used for detecting cardiovascular diseases, angina pectoris, atherosclerosis, heart failure, and other conditions. They are employed by a range of end-users, including hospitals, cardiac centers, home care settings, and more.
Tariffs are impacting the mobile cardiac telemetry systems market by increasing costs for imported electronic components, sensors, and wireless communication modules. These impacts are most prominent in north america and asia-pacific, where telemetry device manufacturing relies on global supply chains. Higher costs have influenced pricing for hospitals, cardiac centers, and home care providers. However, tariffs have also encouraged localized manufacturing, component sourcing diversification, and investment in domestic production capabilities, supporting long-term supply stability.
The mobile cardiac telemetry systems market research report is one of a series of new reports from The Business Research Company that provides mobile cardiac telemetry systems market statistics, including mobile cardiac telemetry systems industry global market size, regional shares, competitors with a mobile cardiac telemetry systems market share, detailed mobile cardiac telemetry systems market segments, market trends and opportunities, and any further data you may need to thrive in the mobile cardiac telemetry systems industry. This mobile cardiac telemetry systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The mobile cardiac telemetry systems market size has grown strongly in recent years. It will grow from $1.06 billion in 2025 to $1.16 billion in 2026 at a compound annual growth rate (CAGR) of 10.0%. The growth in the historic period can be attributed to rising prevalence of cardiovascular diseases, growing incidence of arrhythmias, limitations of traditional holter monitoring, increasing aging population, expanding use of outpatient cardiac diagnostics.
The mobile cardiac telemetry systems market size is expected to see strong growth in the next few years. It will grow to $1.7 billion in 2030 at a compound annual growth rate (CAGR) of 9.9%. The growth in the forecast period can be attributed to growing adoption of remote patient monitoring, increasing demand for early cardiac event detection, expansion of home-based healthcare services, rising focus on continuous real-time cardiac data, improving access to digital cardiac care solutions. Major trends in the forecast period include rising adoption of continuous remote cardiac monitoring, growing shift toward ambulatory and home-based cardiac care, increasing use of patch-based cardiac telemetry devices, expansion of real-time arrhythmia detection and alert systems, growing demand for long-term cardiac rhythm monitoring.
The increasing incidence of cardiovascular disease is anticipated to drive the growth of the mobile cardiac telemetry systems market in the future. Cardiovascular diseases encompass a range of conditions affecting the heart and blood vessels, including coronary artery disease, heart failure, arrhythmias, and hypertension, which can result in severe health complications such as heart attacks, strokes, and other cardiovascular events. The prevalence of cardiovascular disease is rising due to growing risk factors such as sedentary lifestyles, poor diets, obesity, and aging populations. Mobile cardiac telemetry systems provide continuous, real-time monitoring and early detection of cardiac arrhythmias in patients with cardiovascular conditions. For example, in January 2024, the American Heart Association, a US-based nonprofit organization, reported a slight increase in cardiovascular-related deaths this year, reaching 931,578, a marginal rise of 3,000 compared to the previous year's total of 928,741. Consequently, the rising incidence of cardiovascular disease is fueling the growth of the mobile cardiac telemetry systems market.
Leading companies in the mobile cardiac telemetry systems market are developing innovative solutions, such as advanced wearable ECG devices, to improve real-time cardiac data accuracy and support remote patient management. ECG devices are medical instruments that record the heart's electrical activity to detect and monitor cardiovascular conditions. For example, in October 2023, Biotricity Inc., a US-based medical diagnostics company, launched BioTresPro, a next-generation three-channel wearable cardiac monitoring device designed for continuous real-time telemetry. The system features integrated cellular backup for reliable data transmission, continuous multi-lead ECG acquisition for enhanced signal quality, and improved remote connectivity that ensures uninterrupted monitoring even in areas with limited coverage. These capabilities enable clinicians to detect critical cardiac events more quickly and make faster care decisions for patients under ambulatory monitoring.
In May 2024, WearLinq, Inc., a US-based healthcare technology company, acquired AMI Cardiac Monitoring LLC for $6.7 million. Through this acquisition, WearLinq aims to significantly expand its clinical service offerings and enhance cardiac diagnostic capabilities across the United States. AMI Cardiac Monitoring LLC specializes in providing remote cardiac monitoring services.
Major companies operating in the mobile cardiac telemetry systems market are Medtronic PLC, Philips Healthcare, Boston Scientific Corporation, iRhythm Technologies Inc., Biotricity Inc., Zoll Medical Corporation, Spacelabs Healthcare, Infobionic Inc., Medicomp Inc., ScottCare Corporation, Medicalgorithmics S.A., Ambucor Health Solutions Inc., Telerhythmics LLC, Vitaphone GmbH, Card Guard, Heart Test Laboratories Inc., Reactdx, Nuvant Health, Bittium Corporation, Fukuda Denshi Co Ltd, GE HealthCare, Mindray Medical International
North America was the largest region in the mobile cardiac telemetry systems market in 2025. The regions covered in the mobile cardiac telemetry systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the mobile cardiac telemetry systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The mobile cardiac telemetry systems market consists of sales of wearable sensors, transmitter devices, and data transmission units. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Mobile Cardiac Telemetry Systems Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses mobile cardiac telemetry systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for mobile cardiac telemetry systems ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The mobile cardiac telemetry systems market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.